Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in the conjunctiva - A potential link between lymphangiogenesis and leukocyte trafficking on the ocular surface

Advances in Experimental Medicine and Biology

Volumn 506 B, Issue , 2002, Pages 851-860

  Hamrah, Pedram ^a   Zhang, Qiang ^a   Dana, M Reza ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN E; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL COUNT; CELL MIGRATION; CELL SHAPE; CELL SURVIVAL; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONJUNCTIVA; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA NEOVASCULARIZATION; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LEUKOCYTE; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR DENSITY; REGULATORY MECHANISM; UPREGULATION; VASCULAR ENDOTHELIUM;

ANIMALIA;

EID: 0036921850     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0717-8_120     Document Type: Conference Paper

References (36)

1. H.B. Collin. Corneal lymphatics in alloxan vascularized rabbit eyes. Invest Ophthalmol Vis Sci, 5:1 (1966).
2. H.B. Collin. Endothelial cell lined lymphatics in vascularized rabbit cornea. Invest Ophthalmol Vis Sci, 5:337 (1966).
3. H.B. Collin. The fine structure of growing corneal lymphatic vessels. J Pathol, 104:99 (1971).
4. P.C. Burger, and G.K. Klintworth. Autoradiographic study of corneal neovascularization induced by chemical cautery. Lab Invest, 45:328 (1981).
5. 131I-albumin from the vascularized cornea. Invest Ophthalmol Vis Sci, 9:146 (1970).
6. M. Fine, and M. Stein. The role of corneal vascularization in human graft rejection. Corneal graft failure ciba foundation symposium. Amsterdam, Holland: Assoc. Scientific Publishers; 1973:193.
7. S. Yamagami, and M.R. Dana. The critical role of draining lymph nodes in corneal allosensitization. Invest Ophthalmol Vis Sci, 42:1293 (2001).
8. D.R. Senger, S.S. Galli, A.M. Dvorak, C.A. Perruzzi, V.S. Harvey, and H.F. Dvorak. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science, 219:983 (1983).
9. N. Ferrera, and T. Davis-Smyth. The biology of vascular endothelial growth factor. Endocrine Rev, 18:4 (1997).
10. H.F. Dvorak, L.F. Brown, M. Detmar, and A.M. Dvorak. Vascular permeability factor/vascular endothelial growth factor, microvascular permeability, and angiogenesis. Am J Pathol, 146:1029 (1995).
11. V. Joukov, K. Pajusola, A. Kaipainen, D. Chilov, I. Lahtinen, E. Kukk, O. Saksela, N. Kalkkinen, and K. Alitalo. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the FLT4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J, 15:290 (1996).
12. E. Kukk, A. Lymboussaki, S. Taira, A. Kaipainen, M. Jeltsch, V. Joukov, and K. Alitalo. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development, 122:3829 (1996).
13. M.G. Achen, M. Jeltsch, E. Kukk, T. Mäkinen, A. Vitali, A.F. Wilks, K. Alitalo, and S.A. Stacker. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (FLK1) and VEGF receptor 3 (FLT4). Proc Natl Acad Sci USA, 95:548 (1998).
14. J. Lee, A. Gray, J. Yuan, S.-M. Luoh, H. Avraham, and W.I. Wood. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci USA, 93:1988 (1996).
15. Y. Cao, P. Linden, J. Farnebo, R. Cao, A. Eriksson, V. Kumar, J.-H. Qi, L. Claesson-Welsh, and K. Alitalo. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA, 95:14389 (1998).
16. M. Jeltsch, A. Kaipainen, V. Joukov, X. Meng, M. Lakso, H. Rauvala, M. Swartz, D. Fukumura, R.K. Jain, and K. Alitalo. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science, 276:1423 (1997).
17. S.J. Oh, M.M. Jeltsch, R. Birkenhäger, J.E.G. McCarthy, H.A. Weich, B. Christ, K. Alitalo, and J. Wilting. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol, 188:96 (1997).
18. V. Joukov, T. Sorsa, V. Kumar, M. Jeltsch, L. Claesson-Welsh, Y. Cao, O. Saksela, N. Kalkkinen, and K. Alitalo. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J, 16:3898 (1997).
19. K. Pajusola, O. Aprelikova, G. Pelicci, H. Weich, L. Claesson-Welsh, and K. Alitalo. Signalling properties of Flt4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene, 9:3545 (1994).
20. B. Olofsson, M. Jeltsch, U. Eriksson, and K. Alitalo. Current biology of VEGF-B and VEGF-C. Curr Opin Biotechnol, 10:528 (1999).
21. A. Kaipainen, J. Korhonen, T. Mustonen, V.W.M. van Hinsbergh, G.H. Fang, D.J. Dumont, M. Breitman, and K. Alitalo. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA, 92:3566 (1995).
22. G. Smith, D. McLeod, D. Foreman, and M. Boulton. Immunolocalisation of the VEGF receptors Flt-1, KDR, and Fit-4 in diabetic retinopathy. Br J Ophthalmol, 83:486 (1999).
23. T. Mimura, S. Amano, T. Usui, Y. Kaji, T. Oshika, and Y. Ishii. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis. Exp Eye Res, 72:71 (2001).
24. M.R. Dana, and J.W. Streilein. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci, 37:2485 (1996).
25. A. Lymboussaki, T.A. Partanen, B. Olofsson, J. Thomas-Crusells, C.D.M. Fletcher, R.M.W. de Waal, A. Kaipainen, and K. Alitalo. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol, 153:395 (1998).
26. L. Jussila, R. Valtola, T.A. Partanen, P. Salven, P. Heikkilä, M.T. Matikainen, R. Renkonen, A. Kaipainen, M. Detmar, E. Tschachler, R. Alitalo, and K. Alitalo. Lymphatic endothelium and kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res, 58:1599 (1998).
27. J. Wilting, A. Eichmann, and B. Christ. Expression of the avian VEGF receptor homologues quek1 and quek2 in blood-vascular and lymphatic endothelial and non-endothelial cells during quail embryonic development. Cell Tiss Res, 288:207 (1997).
28. L. Marconcini, S. Marchio, L. Morbidelli, E. Cartocci, A. Albini, M. Ziche, F. Bussolino, and S. Oliviero. C-fos-induced growth factor / vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc Natl Acad Sci USA, 96:9671 (1999).
29. B. Witzenbichler, T. Asahara, T. Murohara, M. Silver, I. Spyridopoulos, M. Magner, N. Principe, M. Kearney, J.S. Hu, and J.M. Isner. Vascular endothelial growth factor-c (vegf-c/vegf-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol, 153:381 (1998).
30. D. Chilov, E. Kukk, S. Taira, M. Jeltsch, J. Kaukonen, A. Palotie, V. Joukov, and K. Alitalo. Genomic organization of human and mouse genes for vascular endothelial growth factor C. J Biol Chem, 272:25176 (1997).
31. + hematopoietic progenitors from human cord blood differentiate along two independant dendritic cell pathways in response to GM-CSF + TNFα. J Exp Med, 184:695 (1996).
32. + hematopoietic progenitors from human cord blood differentiate along two independant dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor α: II. Functional analysis. Blood, 90:1458 (1997).
33. S. Marchiò, L. Prima, M. Pagano, G. Palestro, A. Albini, T. Veikkola, I. Cascone, K. Alitalo, and F. Bussolino. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells. J Biol Chem, 274:27617 (1999).
34. M. Clauss, M. Gerlach, H. Gerlach, J. Brett, F. Wang, P.C. Familetti, Y.C.E. Pan, J.V. Olander, D.T. Connolly, and D. Stern. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med, 172:1535 (1990).
35. H. Shen, M. Clauss, J. Ryan, A.M. Schmidt, P. Tijburg, L. Borden, D. Connolly, D. Stern, and J. Kao. Characterization of vascular permeability factor / vascular endothelial growth factor receptors on mononuclear phagocytes. Blood, 81:2767 (1993).
36. M. Clauss, H. Weich, G. Breier, U. Knies, W. Röckl, J. Waltenberger, and W. Risau. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. J Biol Chem, 271:17629 (1996).